Recent advances in cardio‐oncology: a report from the ‘Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019’

While anti‐cancer therapies, including chemotherapy, immunotherapy, radiotherapy, and targeted therapy, are constantly advancing, cardiovascular toxicity has become a major challenge for cardiologists and oncologists. This has led to an increasing demand of cardio‐oncology units in Europe and a grow...

Descripción completa

Detalles Bibliográficos
Autores principales: Anker, Markus S., Hadzibegovic, Sara, Lena, Alessia, Belenkov, Yury, Bergler‐Klein, Jutta, de Boer, Rudolf A., Farmakis, Dimitrios, von Haehling, Stephan, Iakobishvili, Zaza, Maack, Christoph, Pudil, Radek, Skouri, Hadi, Cohen‐Solal, Alain, Tocchetti, Carlo G., Coats, Andrew J.S., Seferović, Petar M., Lyon, Alexander R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
ESC and HFA Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989292/
https://www.ncbi.nlm.nih.gov/pubmed/31884717
http://dx.doi.org/10.1002/ehf2.12551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989292/
https://www.ncbi.nlm.nih.gov/pubmed/31884717
http://dx.doi.org/10.1002/ehf2.12551

Ejemplares similares